What’s more, Kondengaden et al. observed that a new G9a inhibitor DCG066 inhibits cell growth, blocks the cell cycle and induces apoptosis in leukemia cell lines identified through structure-based virtual screening [134], which means that targeting HOXA9 might be indirectly achieved by targeting G9a in various solid tumors. This evidence concerns the gene EHMT2 and leukemia.